ArticleOpen forum infectious diseases2026
Durability and Breadth of Neutralizing Antibodies Against SARS-CoV-2 Variants Following XBB.1.5 Vaccination in a Multiply Exposed Cohort.
Wei Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.